149 related articles for article (PubMed ID: 6159904)
21. Fenbufen and indomethacin: a comparative study in rheumatoid arthritis.
Burton WD; Hazleman BL
Clin Ther; 1983; 5(3):260-7. PubMed ID: 6342784
[TBL] [Abstract][Full Text] [Related]
22. Fenbufen in patients with gastric intolerance.
Paice EW; Tookman AJ; White AG
Eur J Rheumatol Inflamm; 1982; 5(3):301-3. PubMed ID: 7084291
[TBL] [Abstract][Full Text] [Related]
23. [Clinical study of long term administration of fenbufen in rheumatoid arthritis].
Soldati R; Sorbilli G; Di Benedetto P
Clin Ter; 1980 Aug; 94(4):445-59. PubMed ID: 7460498
[No Abstract] [Full Text] [Related]
24. Single-dose pharmacokinetic study of 900 mg fenbufen in the elderly.
Braverman AM
Eur J Rheumatol Inflamm; 1982; 5(3):304-7. PubMed ID: 7084292
[TBL] [Abstract][Full Text] [Related]
25. Long-term safety of benoxaprofen.
Mikulaschek WM
J Rheumatol Suppl; 1980; 6():100-7. PubMed ID: 6993665
[TBL] [Abstract][Full Text] [Related]
26. Fenbufen based 3-[5-(substituted aryl)-1,3,4-oxadiazol-2-yl]-1-(biphenyl-4-yl)propan-1-ones as safer antiinflammatory and analgesic agents.
Husain A; Ahmad A; Alam MM; Ajmal M; Ahuja P
Eur J Med Chem; 2009 Sep; 44(9):3798-804. PubMed ID: 19457595
[TBL] [Abstract][Full Text] [Related]
27. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
28. A six-month parallel group comparison of fenbufen and naproxen in the treatment of rheumatoid arthritis.
Khan FM
Clin Ther; 1983; 5(5):483-7. PubMed ID: 6352034
[TBL] [Abstract][Full Text] [Related]
29. Fenbufen: a review of its pharmacological properties and therapeutic use in rheumatic diseases and acute pain.
Brogden RN; Heel RC; Speight TM; Avery GS
Drugs; 1981 Jan; 21(1):1-22. PubMed ID: 7009135
[TBL] [Abstract][Full Text] [Related]
30. Pharmacologic properties of fenbufen.
Kerwar SS
Am J Med; 1983 Oct; 75(4B):62-9. PubMed ID: 6356910
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of prostaglandin activity and synthesis by fenbufen (a new nonsteroidal antiinflammatory agent) and one of its metabolites.
Tolman EL; Birnbaum JE; Chiccarelli FS; Panagides J; Sloboda AE
Adv Prostaglandin Thromboxane Res; 1976; 1():133-8. PubMed ID: 826139
[No Abstract] [Full Text] [Related]
32. The acute action of fenbufen and piroxicam on the gastric mucosa as measured by gastric microbleeding.
Collins AJ; Notarianni LJ
J Int Med Res; 1984; 12(3):179-83. PubMed ID: 6610580
[TBL] [Abstract][Full Text] [Related]
33. Prescription-event monitoring. A preliminary study of benoxaprofen and fenbufen.
Inman WH
Acta Med Scand Suppl; 1984; 683():119-26. PubMed ID: 6234753
[TBL] [Abstract][Full Text] [Related]
34. Fenbufen: goes down well!
Hopkins SJ
Nurs Mirror; 1981 Dec; 153(23):53. PubMed ID: 6914665
[No Abstract] [Full Text] [Related]
35. Studies on an anti-inflammatory agent. III. Pharmacological investigations of a new non-steroidal anti-inflammatory agent: 2-oxo-3-[4-(1-oxo-2-isoindolinyl)-phenyl]-butanamide (GP 650).
Fukawa K; Kanezuka T; Ohba S; Kawano O; Hibi M; Misaki N; Sawabe T
Arzneimittelforschung; 1982; 32(3):225-30. PubMed ID: 6979341
[TBL] [Abstract][Full Text] [Related]
36. The pharmacological profile of 2-(8-methyl-10,11-dihydro-11-oxodibenz[b,f]oxepin-2-yl)propionic acid (AD-1590), a new non-steroidal anti-inflammatory agent with potent antipyretic activity.
Nakamura H; Yokoyama Y; Motoyoshi S; Ishii K; Imazu C; Seto Y; Kadokawa T; Shimizu M
Arzneimittelforschung; 1983; 33(11):1555-69. PubMed ID: 6607053
[TBL] [Abstract][Full Text] [Related]
37. [Severe vasculitis during treatment with fenbufen].
Jean-Pastor MJ; Jean P; Garbe L; Andrac L; Lauret Y; Jouglard J
Therapie; 1984; 39(3):305-9. PubMed ID: 6463955
[No Abstract] [Full Text] [Related]
38. Preclinical studies on indoprofen, a new non-steroidal analgesic-antiinflammatory agent.
Buttinoni A; Tommasini R
Eur J Rheumatol Inflamm; 1981; 4(1):3-10. PubMed ID: 6804240
[TBL] [Abstract][Full Text] [Related]
39. Acute, subacute and chronic toxicity of oxepinac.
Nomura M; Onodera T; Kato M; Yamada A; Ogawa H; Akimoto T
Arzneimittelforschung; 1978; 28(3):445-51. PubMed ID: 580754
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological properties of a new anti-inflammatory agent: 2-(2-isopropyl-5-indanyl)propionic acid (UP 517-03).
Hertz F; Ranson M; Lwoff JM
Arzneimittelforschung; 1980; 30(9):1549-57. PubMed ID: 6970037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
